Crysticillin 300 A.S. en es it fr

Crysticillin 300 A.S. Brand names, Crysticillin 300 A.S. Analogs

Crysticillin 300 A.S. Brand Names Mixture

  • No information avaliable

Crysticillin 300 A.S. Chemical_Formula

C16H18N2O4S

Crysticillin 300 A.S. RX_link

http://www.rxlist.com/cgi/generic3/pengk.htm

Crysticillin 300 A.S. fda sheet

Crysticillin 300 A.S. msds (material safety sheet)

Crysticillin_300_A.S. MSDS

Crysticillin 300 A.S. Synthesis Reference

No information avaliable

Crysticillin 300 A.S. Molecular Weight

334.391 g/mol

Crysticillin 300 A.S. Melting Point

214-217oC

Crysticillin 300 A.S. H2O Solubility

Slightly soluble (210 mg/L)

Crysticillin 300 A.S. State

Solid

Crysticillin 300 A.S. LogP

1.212

Crysticillin 300 A.S. Dosage Forms

Powder for solution; Suspension; Tablet

Crysticillin 300 A.S. Indication

For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required.

Crysticillin 300 A.S. Pharmacology

Penicillin G is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Penicillin G has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of penicillin G results from the inhibition of cell wall synthesis and is mediated through penicillin G binding to penicillin binding proteins (PBPs). Penicillin G is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Crysticillin 300 A.S. Absorption

Rapidly absorbed following both intramuscular and subcutaneous injection. Initial blood levels following parenteral administration are high but transient.

Crysticillin 300 A.S. side effects and Toxicity

Oral LD50 in rat is 8900 mk/kg. Neurological adverse reactions, including convulsions, may occur with the attainment of high CSF levels of beta-lactams.

Crysticillin 300 A.S. Patient Information

No information avaliable

Crysticillin 300 A.S. Organisms Affected

Enteric bacteria and other eubacteria